Metraipolis › archive › dc_bb1976d3e13c
Risk-adapted first-line therapy selection in advanced EGFR-mutant NSCLC: a practical clinical algorithm integrating tumor biology and patient factors — Europe PMC PMID:42667515
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42667515
- DOI
- 10.1007/s12032-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T17:48:38.552Z
- SHA-256 of the archived text
d0c809210bb2729bfa6e76f764a73d3ff7f50d102942e49aad7bdeb37d13fbd1- Stable URL of this page
https://metraipolis.com/documento/dc_bb1976d3e13c
How to cite
Risk-adapted first-line therapy selection in advanced EGFR-mutant NSCLC: a practical clinical algorithm integrating tumor biology and patient factors — Europe PMC PMID:42667515 — Europe PMC (en), https://europepmc.org/article/MED/42667515 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb1976d3e13c (Metraipolis archive dc_bb1976d3e13c, sha256 d0c809210bb2729bfa6e76f764a73d3ff7f50d102942e49aad7bdeb37d13fbd1)
BibTeX
@misc{dcbb1976d3e13c,
title = {Risk-adapted first-line therapy selection in advanced EGFR-mutant NSCLC: a practical clinical algorithm integrating tumor biology and patient factors — Europe PMC PMID:42667515},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42667515},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb1976d3e13c; sha256 d0c809210bb2729bfa6e76f764a73d3ff7f50d102942e49aad7bdeb37d13fbd1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42667515. Agents can read the archived copy with the MCP tool read_document.